MX2010005385A - Medicamentos topicos para la terapia antimicotica. - Google Patents
Medicamentos topicos para la terapia antimicotica.Info
- Publication number
- MX2010005385A MX2010005385A MX2010005385A MX2010005385A MX2010005385A MX 2010005385 A MX2010005385 A MX 2010005385A MX 2010005385 A MX2010005385 A MX 2010005385A MX 2010005385 A MX2010005385 A MX 2010005385A MX 2010005385 A MX2010005385 A MX 2010005385A
- Authority
- MX
- Mexico
- Prior art keywords
- topical drugs
- antifungal therapy
- antifungal
- drugs
- active substance
- Prior art date
Links
- 230000000843 anti-fungal effect Effects 0.000 title abstract 3
- 229940121375 antifungal agent Drugs 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- 229940055726 pantothenic acid Drugs 0.000 abstract 1
- 235000019161 pantothenic acid Nutrition 0.000 abstract 1
- 239000011713 pantothenic acid Substances 0.000 abstract 1
- 150000002948 pantothenic acids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07022353 | 2007-11-17 | ||
| PCT/EP2008/009686 WO2009062746A2 (fr) | 2007-11-17 | 2008-11-15 | Médicaments topiques pour le traitement antimycotique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010005385A true MX2010005385A (es) | 2010-07-30 |
Family
ID=40214317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010005385A MX2010005385A (es) | 2007-11-17 | 2008-11-15 | Medicamentos topicos para la terapia antimicotica. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2222319A2 (fr) |
| AU (1) | AU2008323165A1 (fr) |
| CA (1) | CA2705815A1 (fr) |
| MX (1) | MX2010005385A (fr) |
| WO (1) | WO2009062746A2 (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9687429B2 (en) | 2007-06-20 | 2017-06-27 | The Trustees Of Columbia University In The City Of New York | Antimicrobial compositions containing low concentrations of botanicals |
| US9981069B2 (en) | 2007-06-20 | 2018-05-29 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
| US8932624B2 (en) | 2007-06-20 | 2015-01-13 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
| US9511040B2 (en) | 2007-06-20 | 2016-12-06 | The Trustees Of Columbia University In The City Of New York | Skin and surface disinfectant compositions containing botanicals |
| EP2448416A4 (fr) * | 2009-06-30 | 2013-03-20 | Univ Columbia | Compositions antimicrobiennes/de conservation comprenant des agents botaniques |
| IT1400726B1 (it) * | 2009-07-24 | 2013-07-02 | Vi Rus S R L | Composizione di un'emulsione ad uso topico a base di clotrimazolo, clorexidina digluconato,acido salicilico,allantoina,pantenolo,zinco,acido glicirretico,olio di mandorle dolci,olio di riso,mentile lattato indicata nel trattamento delle infezioni micotiche della cute e dei suoi annessi. |
| WO2011061155A1 (fr) * | 2009-11-17 | 2011-05-26 | Bayer Consumer Care Ag | Formulations antifongiques et leur utilisation |
| GB201107176D0 (en) * | 2011-04-28 | 2011-06-15 | Cxr Biosciences Ltd | Pyrrolnitrin derivatives |
| US9968101B2 (en) | 2011-11-03 | 2018-05-15 | The Trustees Of Columbia University In The City Of New York | Botanical antimicrobial compositions |
| DK2773334T3 (da) | 2011-11-03 | 2019-12-09 | Univ Columbia | Sammensætning med forlænget antimikrobiel aktivitet |
| WO2013086094A1 (fr) | 2011-12-06 | 2013-06-13 | The Trustees Of Columbia University In The City Of New York | Composition d'agent de conservation naturelle à large spectre |
| JP6194003B2 (ja) | 2012-10-09 | 2017-09-06 | ザ プロクター アンド ギャンブル カンパニー | 有益剤及びこれを含む組成物の特定又は評価方法 |
| EP2906197A1 (fr) | 2012-10-09 | 2015-08-19 | The Procter & Gamble Company | Procédé d'identification de combinaisons cosmétiques synergiques |
| US9138393B2 (en) | 2013-02-08 | 2015-09-22 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
| US9144538B2 (en) | 2013-02-08 | 2015-09-29 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin |
| WO2017031075A1 (fr) * | 2015-08-17 | 2017-02-23 | Arno Therapeutics, Inc. | Procédés et compositions pour une administration transunguéale améliorée d'ar-12 |
| WO2017091167A1 (fr) * | 2015-11-28 | 2017-06-01 | Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. | Composition pharmaceutique topique comprenant de l'acide fusidique, de l'isoconazole, du dexpanthénol et de l'hydrocortisone |
| KR102217617B1 (ko) * | 2020-08-14 | 2021-02-19 | 비엘엔에이치 주식회사 | 백선의 예방 또는 치료용 약학적 조성물 |
| CN113440483B (zh) * | 2021-06-30 | 2023-04-07 | 佛山市南海东方澳龙制药有限公司 | 一种犬用盐酸特比萘芬喷剂及其制备方法 |
| WO2024137780A1 (fr) * | 2022-12-21 | 2024-06-27 | Yale University | Modulateurs de pank et méthodes de traitement les utilisant |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2338248A1 (fr) * | 1976-01-14 | 1977-08-12 | Daunit Jeannine | Pantothenate de zinc et procede d'obtention |
| RO107824B1 (ro) * | 1991-01-30 | 1994-01-31 | Maria Gaidargiu | Șampon pentru păr |
| US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| CA2343284C (fr) * | 1998-09-10 | 2008-11-18 | Ipr-Institute For Pharmaceutical Research Ag | Produits pour l'application locale |
| AU2003216034A1 (en) * | 2002-01-21 | 2003-07-30 | Slovakofarma A.S. | Dermatological topical compositions and a process for the preparation thereof |
| DE10361022A1 (de) * | 2003-12-23 | 2005-07-28 | Merckle Gmbh Chem.-Pharm. Fabrik | Topische Zubereitungen enthaltend Dimethylsulfoxid und Dexpanthenol |
| EP1557375A1 (fr) * | 2004-01-23 | 2005-07-27 | Neubourg Skin Care GmbH & Co. KG | Bombe aérosol pour teinture des ongles |
-
2008
- 2008-11-15 WO PCT/EP2008/009686 patent/WO2009062746A2/fr active Application Filing
- 2008-11-15 AU AU2008323165A patent/AU2008323165A1/en not_active Abandoned
- 2008-11-15 CA CA2705815A patent/CA2705815A1/fr not_active Abandoned
- 2008-11-15 EP EP08850735A patent/EP2222319A2/fr not_active Withdrawn
- 2008-11-15 MX MX2010005385A patent/MX2010005385A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2222319A2 (fr) | 2010-09-01 |
| WO2009062746A3 (fr) | 2009-08-13 |
| WO2009062746A2 (fr) | 2009-05-22 |
| CA2705815A1 (fr) | 2009-05-22 |
| AU2008323165A1 (en) | 2009-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010005385A (es) | Medicamentos topicos para la terapia antimicotica. | |
| AP2405A (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms. | |
| DK2010190T3 (da) | Farmaceutisk opløsningsformulering til tryksatte, dosisregulerede inhalatorer | |
| TN2012000216A1 (en) | Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine | |
| CY1119798T1 (el) | Μορφη iv υδροχλωρικης ιβαμπραδινης | |
| HK1134041A1 (en) | Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same | |
| ZA201000185B (en) | 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative | |
| WO2012156296A8 (fr) | Combinaison pharmaceutique destinée à être utilisée pour induire une perte de poids chez des patients atteints de diabète de type 2 et/ou pour empêcher une prise de poids chez des patients atteints de diabète de type 2 | |
| IL196394A0 (en) | Implantable sustained drug delivery device for releasing active agents to the osteomeatal complex | |
| WO2009071689A3 (fr) | Dérivés d'oxindole substitués par halogène en position 5 et leur utilisation pour traiter des maladies liées à la vasopressine | |
| BRPI1009823A2 (pt) | "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit." | |
| PH12018500368A1 (en) | Preparations containing amorphous emodepside | |
| EP2167490A4 (fr) | Dérivés triazoles ayant une activité antifongique, leur procédé de preparation, et composition pharmaceutique comportant de tels dérivés | |
| IL209304A0 (en) | Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition | |
| WO2011014003A3 (fr) | Dérivés de (+)-3-(+)-3-hydroxymorphinan utilisés comme neuroprotecteurs | |
| ZA201000187B (en) | 17b-cyano-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative | |
| ZA200802187B (en) | Drug delivery system for topical administration | |
| ZA201000186B (en) | 17b-cyano-19-androst-4-ene derivative,use thereof and medicaments containing said derivative | |
| WO2009010298A8 (fr) | Dérivés de paullone et leurs utilisation | |
| ZA201005394B (en) | 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative | |
| ZA201005396B (en) | 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative,use thereof,and medicament containing the derivative | |
| ZA200904563B (en) | Transdermal Therapeutic system for administering water-soluble active ingredients | |
| GB0517838D0 (en) | Transdermal active principle delivery means | |
| ZA201005397B (en) | 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative,use thereof,and medicament containing said derivative | |
| TW200833325A (en) | Pharmaceutical composition comprising ascorbic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |